Reported 2 days ago
Johnson & Johnson (JNJ) has been highlighted as a top value stock within billionaire investor Ken Fisher's portfolio, showing resilience amid ongoing market corrections due to trade tensions. The company boasts a diverse portfolio in healthcare, including a promising cancer division expected to drive significant growth. With a forward P/E ratio of 14.58 and a consistent history of dividend payments, JNJ ranks as a solid investment option, even as Fisher remains optimistic about a market rebound despite current economic concerns.
Source: YAHOO